植物性全食物饮食在自体造血干细胞移植期间可行且与剂量依赖性微生物组调节相关
该单臂临床试验纳入22例接受自体造血干细胞移植的多发性骨髓瘤患者,在预处理、中性粒细胞减少及早期恢复共5周内提供新鲜预制植物性餐食。主要终点为可行性与耐受性,结果显示干预可行且耐受良好,摄入量越高与肠道微生物组向产短链脂肪酸类群富集及粪便短链脂肪酸浓度升高相关。
要点
- 植物性全食物餐食在auto-HCT期间可行且耐受良好
- 研究餐食摄入量越高,肠道微生物组改变越明显
- 粪便短链脂肪酸浓度从基线至干预结束升高
核心结论
- 植物性餐食配送干预在auto-HCT期间可实施,并提示对肠道微生物组及其代谢输出存在剂量依赖性调节。
研究设计与样本
- 单臂临床试验,纳入22例接受auto-HCT的多发性骨髓瘤患者。
- 干预为5周新鲜预制植物性餐食,覆盖预处理、中性粒细胞减少及早期恢复期。
- 主要终点为可行性与耐受性,以成功入组和患者报告的研究餐食摄入定义。
- 饮食摄入通过前瞻性食物日记和24小时膳食回顾调查量化。
- 次要终点包括鸟枪法宏基因组测序评估的肠道微生物组组成与功能变化及粪便短链脂肪酸测定。
主要发现
- 所有参与者均一定程度上食用了配送餐食,依从性足以支持计划的饮食和相关分析。
- 研究餐食摄入量越高,肠道微生物群落变化越明显,包括产短链脂肪酸类群富集及符合纤维响应性微生物组的组成改变。
- 粪便短链脂肪酸浓度从基线至干预结束升高。
临床怎么用
- 植物性全食物餐食配送可作为auto-HCT期间可行的营养干预策略。
- 摄入量越高与微生物组调节越明显相关,支持剂量-效应关系。
局限性
- 单臂设计,样本量22例,无法确立因果或与对照组的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Plant-based whole food diets may represent a tractable approach to mitigating microbiome disruption and improving outcomes in patients undergoing autologous hematopoietic cell transplantation (auto-HCT) for multiple myeloma, a population in whom intestinal dysbiosis has been linked with inferior survival. We conducted a single-arm clinical trial at our center, in which participants undergoing auto-HCT (n = 22) received fresh, pre-prepared, plant-based meals for 5 weeks spanning conditioning, neutropenia, and early recovery, with the goal of supporting the consumption of nutrient-dense, high-fiber foods. The primary end points were feasibility and tolerability, defined by successful enrollment and patient-reported intake of study meals. Dietary intake was quantified using prospective food diaries and 24-hour dietary recall surveys. Secondary end points included changes in gut microbiome composition and function assessed by shotgun metagenomic sequencing and stool short-chain fatty acid (SCFA) measurements. The intervention was feasible and generally well tolerated, with all participants consuming delivered meals to some degree, with adherence sufficient to support planned dietary and correlative analyses. Greater intake of study meals was associated with more pronounced shifts in gut microbial communities, including enrichment of SCFA-producing taxa and compositional changes consistent with a fiber-responsive microbiome. Stool SCFA concentrations increased from baseline to the end of the intervention, suggesting a potential influence of the dietary strategy on microbial metabolite production during the peritransplant period. These findings demonstrate that a plant-based meal delivery intervention is implementable during auto-HCT and suggest dose-dependent modulation of the gut microbiome and its metabolic output. The trial was registered at ClinicalTrials.gov as NCT06559709.
引用
- Ueland K, Elahi T, Rasmussen M, et al. Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation. Blood Adv. 2026. PMID: 42263665. doi:10.1182/bloodadvances.2026020270
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。